ANTX
UNKNOWNAN2 Therapeutics, Inc.
CIK: 0001880438
Sell
(70% confidence)
Last activity: Jan 6, 2026
Financial Metrics
As of Dec 31, 2024 (10-K)
Current Ratio 6.14
Insider Roster (4 total, 4 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Eizen Joshua M See Remarks | 0 | 2 | -$25K | 152,499 shares $154K |
| Chanda Sanjay Chief Development Officer | 0 | 2 | -$9K | 75,823 shares $77K |
| Day Lucy Chief Financial Officer | 0 | 2 | -$9K | 75,363 shares $76K |
| Prior Stephen David Chief Strategy Officer | 0 | 2 | -$7K | 59,086 shares $60K |
Recent Transactions
SELL Eizen Joshua M (See Remarks)
6,931 shares @ $1.01
$7K
Jan 6, 2026
Conviction: |
View SEC Filing →
SELL Chanda Sanjay (Chief Development Officer)
5,956 shares @ $1.01
$6K
Jan 6, 2026
Conviction: |
View SEC Filing →
SELL Day Lucy (Chief Financial Officer)
5,512 shares @ $1.01
$6K
Jan 6, 2026
Conviction: |
View SEC Filing →
SELL Prior Stephen David (Chief Strategy Officer)
2,858 shares @ $1.01
$3K
Jan 6, 2026
Conviction: |
View SEC Filing →
SELL Eizen Joshua M (See Remarks)
17,923 shares @ $1.00
$18K
Jan 5, 2026
Conviction: |
View SEC Filing →
SELL Prior Stephen David (Chief Strategy Officer)
3,604 shares @ $1.00
$4K
Jan 5, 2026
Conviction: |
View SEC Filing →
SELL Day Lucy (Chief Financial Officer)
3,295 shares @ $1.00
$3K
Jan 5, 2026
Conviction: |
View SEC Filing →
SELL Chanda Sanjay (Chief Development Officer)
3,295 shares @ $1.00
$3K
Jan 5, 2026
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.